Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2169/naika.89.2347 | DOI Listing |
Cureus
September 2024
Internal Medicine, Ittefaq Hospital, Lahore, PAK.
Pharmaceuticals (Basel)
August 2024
Pulmonology Unit, Department of Medical Surgical and Health Sciences, University of Trieste, 34149 Trieste, Italy.
Radiol Case Rep
December 2024
Department of Internal Medicine, Mohamed Tahar Maamouri University Hospital, Nabeul, Tunisia.
Sarcoidosis is a systemic granulomatosis of unknown etiology. Mediastinal lymph node and pulmonary involvement are the most characteristic manifestations. However, bone involvement is rare during sarcoidosis.
View Article and Find Full Text PDFClin Case Rep
August 2024
Department of General Surgery Saint George Hospital University Medical Center, Saint George University of Beirut Beirut Lebanon.
Key Clinical Message: Sarcoidosis is a systemic granulomatous disease with an unknown cause, marked by the presence of noncaseating granulomas in the affected organs. While the pulmonary interstitium is most frequently involved, the disease can affect almost any other organ system. Extrapulmonary involvement can occur with or without lung involvement, but isolated extrapulmonary involvement is a rare event.
View Article and Find Full Text PDFClin Pract
June 2024
Department of Pathology, University of Missouri, Columbia, MO 65212, USA.
Background: Sarcoidosis is a multisystemic disease that is histologically characterized by non-caseating granulomas in one or more organs. Although hypercalcemia is commonly seen in sarcoidosis, clinically significant hypercalcemia as the initial presentation of sarcoidosis is exceedingly rare. Long-standing hypercalcemia can lead to several complications and needs to be adequately managed to prevent irreversible damage.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!